HIV-1 assembly and release

Information

  • Research Project
  • 9031712
  • ApplicationId
    9031712
  • Core Project Number
    R01AI050111
  • Full Project Number
    4R01AI050111-15
  • Serial Number
    050111
  • FOA Number
    PA-11-260
  • Sub Project Id
  • Project Start Date
    4/1/2001 - 23 years ago
  • Project End Date
    3/31/2017 - 7 years ago
  • Program Officer Name
    CHURCH, ELIZABETH S
  • Budget Start Date
    4/1/2016 - 8 years ago
  • Budget End Date
    3/31/2017 - 7 years ago
  • Fiscal Year
    2016
  • Support Year
    15
  • Suffix
  • Award Notice Date
    3/25/2016 - 8 years ago

HIV-1 assembly and release

DESCRIPTION (provided by applicant): The assembly and release of HIV-1 particles is quite complex, in that a number of viral and cellular RNAs and proteins participate, and while much has been learned about this process, much remains to be discovered. The Gag protein is central to the assembly and release of HIV-1 and all other retrovirus particles. A key function of the Gag protein that will be one focus of tis proposal is the recruitment and packaging of viral genomic RNA (gRNA). Reciprocally, gRNA may help to drive the recruitment of additional Gag molecules into a virion as assembly progresses. However, the full extent to which RNA participates in particle assembly in cells, and how Gag:RNA interactions change as assembly is initiated and completed remain to be defined. The experiments proposed in specific aim 1 will be the first to determine precisely how HIV-1 Gag and gRNA interact in cells. These studies could identify the very first as well as subsequent interactions between Gag protein and gRNA as well as between gRNA and antiviral cytidine deaminases. Following assembly, HIV-1 particles depart from the surface of the infected cell, to colonize neighboring or distal uninfected cells. During the previous funding period, we identified an IFN-induced membrane protein, termed tetherin, as a host defense molecule that inhibits HIV-1 particle release. Our work has demonstrated that tetherin acts directly, to retain nascent virions on the cell surface, but key mechanistic details of how tetherin functions, and what role t plays in preventing the dissemination of viral infection in cultured cells and in vivo remain to b determined. In specific aim 2, we will perform a series of in vitro and in vivo experiments to address these key questions.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    4
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    198750
  • Total Cost
    448750
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:448750\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AARON DIAMOND AIDS RESEARCH CENTER
  • Organization Department
  • Organization DUNS
    786658872
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    100169102
  • Organization District
    UNITED STATES